COMMUNIQUÉ DE PRESSE publié le 23/03/2026 à 11:44, il y a 3 mois 3 jours Viromed Medical AG receives funding approval from the Federal Ministry of Research, Technology and Space for the development of cold plasma technology Viromed Medical AG receives funding approval from the Federal Ministry of Research, Technology and Space for the development of cold plasma technology Research And Development Viromed Medical AG Scientific Innovation Cold Plasma Technology Funding Approval
BRÈVE publiée le 19/03/2026 à 09:05, il y a 3 mois 7 jours Viromed Medical AG nomme Anna Heinen au conseil de surveillance Stratégie D'entreprise Conseil De Surveillance Viromed Medical AG Technologie Du Plasma Froid Anna Heinen
BRÈVE publiée le 19/03/2026 à 09:05, il y a 3 mois 7 jours Viromed Medical AG Appoints Anna Heinen to Supervisory Board Supervisory Board Corporate Strategy Viromed Medical AG Cold Plasma Technology Anna Heinen
COMMUNIQUÉ DE PRESSE publié le 19/03/2026 à 09:00, il y a 3 mois 7 jours Viromed Medical AG: Anna Heinen appointed to the Supervisory Board Anna Heinen appointed to the Supervisory Board of Viromed Medical AG, bringing expertise in corporate strategy and governance. She succeeds Frank Otto Governance Supervisory Board Corporate Strategy Viromed Medical AG Anna Heinen
BRÈVE publiée le 04/03/2026 à 07:49, il y a 3 mois 22 jours Viromed Medical AG entreprend l'acquisition de Relyon Plasma GmbH Acquisition Intégration Stratégique Viromed Medical AG Technologie Du Plasma Froid Relyon Plasma GmbH
BRÈVE publiée le 04/03/2026 à 07:49, il y a 3 mois 22 jours Viromed Medical AG Moves to Acquire Relyon Plasma GmbH Acquisition Strategic Integration Viromed Medical AG Cold Plasma Technology Relyon Plasma GmbH
COMMUNIQUÉ DE PRESSE publié le 04/03/2026 à 07:44, il y a 3 mois 22 jours Viromed Medical AG signs letter of intent to acquire relyon plasma GmbH – Strategic step toward integrated platform for cold plasma technology Viromed Medical AG signs letter of intent to acquire relyon plasma GmbH, a key strategic step towards an integrated platform for cold plasma technology. The acquisition aims to strengthen Viromed's technological position and expand its market presence Acquisition Strategic Integration Viromed Medical AG Cold Plasma Technology Relyon Plasma GmbH
BRÈVE publiée le 03/03/2026 à 17:50, il y a 3 mois 23 jours Viromed Medical AG va acquérir Relieon Plasma GmbH Dispositifs Médicaux Fusions Et Acquisitions Viromed Medical AG Technologie Du Plasma Froid Relion Plasma GmbH
BRÈVE publiée le 03/03/2026 à 17:50, il y a 3 mois 23 jours Viromed Medical AG to Acquire relyon plasma GmbH Medical Devices Mergers And Acquisitions Viromed Medical AG Cold Plasma Technology Relyon Plasma GmbH
COMMUNIQUÉ DE PRESSE publié le 03/03/2026 à 17:45, il y a 3 mois 23 jours EQS-Adhoc: Viromed Medical AG signs letter of intent to acquire relyon plasma GmbH Viromed Medical AG signs letter of intent to acquire relyon plasma GmbH, expanding its value chain and gaining expertise in atmospheric plasma technology Acquisition Letter Of Intent Plasma Technology Viromed Medical AG Relyon Plasma GmbH
Publié le 26/06/2026 à 14:05, il y a 4 heures 27 minutes SouthGobi Announces Voting Results of Annual General Meeting of Shareholders
Publié le 26/06/2026 à 14:00, il y a 4 heures 32 minutes Dateline Chairman Invests $1.95 million through Options Exercise
Publié le 26/06/2026 à 13:00, il y a 5 heures 32 minutes Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Publié le 26/06/2026 à 12:45, il y a 5 heures 47 minutes Northern Dynasty Reports Oral Arguments Held
Publié le 26/06/2026 à 18:04, il y a 28 minutes Turkiye Garanti Bankasi A.S.: Bond, subordinated debts, that can be included in the equity calculation debt instrument issuance CMB Application
Publié le 26/06/2026 à 18:00, il y a 32 minutes PSP Swiss Property has sold the Richtipark in Wallisellen. The EBITDA guidance for the 2026 financial year has been increased.
Publié le 26/06/2026 à 18:00, il y a 32 minutes VALBIOTIS SA: Valbiotis announces the success of its capital increase of €10.2M
Publié le 26/06/2026 à 18:00, il y a 32 minutes VALBIOTIS SA: Valbiotis annonce le succès de son augmentation de capital de 10,2 M€ entièrement dédiée à soutenir l’expansion commerciale de son offre de produits de santé naturels
Publié le 26/06/2026 à 18:00, il y a 32 minutes ROCTOOL: Summary of the Roctool Annual General Meeting held on June 26, 2026